Abstract:Valorar la adecuación del tratamiento farmacológico antihipertensivo prescrito según la patología asociada en cada paciente y analizar el control de cifras tensionales. Estudio descriptivo, transversal. Centro de salud de área urbana. La población diana fueron los pacientes hipertensos en tratamiento farmacológico y controlados en el centro de salud. Se realizó muestreo aleatorio estratificado por cupos del total de hipertensos, y la muestra fue de 219 hipertensos. Se revisó la historia clínica de los pacientes seleccionados. Para la evaluación del tratamiento antihipertensivo establecimos tres niveles de adecuación (adecuado, intermedio y no adecuado) basándonos en el protocolo de hipertensión arterial de 1999 de la Sociedad Española de Medicina de Familia y Comunitaria, teniendo en cuenta la patología concomitante en cada paciente. De 219 casos, el tratamiento fue adecuado en 71 (32,4%), intermedio en 91 (41,6%) y no adecuado en 57 (26%). El grupo farmacológico más frecuentemente indicado fue el de inhibidores de la enzima de conversión de la angiotensina (IECA) y en asociación: IECA + diuréticos. Respecto al control de tensión arterial, un 66,5% presentó un control óptimo, el 23,2% un control parcial y un 9% mal control. Conclusiones. La mayoría de los tratamientos se encuentran en un nivel de adecuación intermedio: sin efectos beneficiosos ni indeseables sobre la patología asociada. Esto nos hace pensar en la necesidad de optimizar las indicaciones farmacológicas antihipertensivas. To assess the suitability of whatever hypertension medication is prescribed for the associated pathology in each patient, and to analyse the monitoring of blood pressure figures. A cross-sectional descriptive study. Urban health centre. The target population were the hypertension patients being treated with medication and monitored at the health centre. Stratified random sampling by quotas of the total number with hypertension was performed. The sample numbered 219 patients. The clinical history of each patient selected was reviewed. To evaluate the hypertension treatment, we established three levels of suitability with regard to the accompanying pathology of each patient (suitable, intermediate, unsuitable), using the 1999 Hypertension Protocol of the Spanish Society of Family and Community Medicine. Out of 219 cases, treatment was suitable in 71 (32.4%), intermediate in 91 (41.6%), and unsuitable in 57 (26%). The most frequently indicated drug group was the angiotensin converting enzyme inhibitor (ACEI) group and, jointly, ACEI and diuretics. Regarding the monitoring of blood pressure: 66.5% had very good monitoring, 23.2% partial and 9% poor. Most treatments are at an intermediate level of suitability: without beneficial or undesirable effects on the associated pathology. This makes us think we need to optimize the drug indicators for hypertension.

Valoración del tratamiento farmacológico antihipertensivo en un centro de salud en función de las patologías crónicas asociadas y grado de control de la HTA

[Assessment of Drug Treatment for Hypertension in a Health Centre As a Function of Associated Chronic Pathologies and Degree of Control of the Hypertension].

[Study on the Compliance of Antihypertensive Drugs in Patients with Hypertension].

P153 NATIONAL SURVEY OF ARGENTINE DOCTORS ON HYPERTENSION

Blood pressure control and management of very elderly patients with hypertension in primary care settings in Spain

Effectiveness of medication self-management, self-monitoring and a lifestyle intervention on hypertension in poorly controlled patients: The MEDICHY randomized trial

Effectiveness of the Combination of Enalapril and Nifedipine for the Treatment of Hypertension versus Empirical Treatment in Primary Care Patients

Abstract P306: A Specific 3-month Nursing Program After Laboratory Detection Of Non-adherence To Medication In Uncontrolled Hypertension Improves Adherence And Blood Pressure Control (ATHAN Trial)

Valores De La Presión De Perfusión Ocular Y Presión Intraocular En Pacientes Con Hipertensión Arterial Sistémica

A SPECIFIC 3 MONTHS-PROGRAM TO IMPROVE NON-ADHERENCE IN UNCONTROLLED HYPERTENSION IMPROVES BLOOD PRESSURE CONTROL AND ASSOCIATED ORGAN DAMAGE (ATHAN CLINICAL TRIAL)

Abstract P255: STUDY OF THE SEVERITY OF COVID-19 IN HYPERTENSIVE PATIENTS IN PRIMARY CARE, IN SPAIN. PRELIMINARY RESULTS.

Empleo de un score semicuantitativo en la valoración de la congestión pulmonar: prevalencia e implicaciones en el manejo diurético tras el alta por insuficiencia cardiaca

Clinical Perspective on Antihypertensive Drug Treatment in Adults with Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: an International Expert Consultation

Nitrendipine and Enalapril Combination Therapy in Mild to Moderate Hypertension: Assessment of Dose-Response Relationship by a Clinical Trial of Factorial Design

Guidelines-based therapeutic strategies for controlling hypertension in non-controlled hypertensive patients followed by family physicians in primary health care in Portugal: the GPHT-PT study

Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation

A16395 Hypertension Management and Effect Analysis on Treatment Flow Path in the Uncontrolled Blood Pressure Patients of Community Health Center

P168 CHARACTERIZATION OF THE HEMODYNAMIC PATTERN OF CONTROLLED HYPERTENSIVE PATIENTS

O44 LOW ADHERENCE TO HYPERTENSION MANAGEMENT IN THE COLOMBIAN COMMUNITY IMPLEMENTATION RE-HOPE STUDY

Management of patients with uncontrolled arterial hypertension – the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCT

Persistence of Treatment and Blood Pressure Control in Elderly Hypertensive Patients Treated With Different Classes of Antihypertensive Drugs